Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Method of producing infectious RSV offered for licensing

Dec. 17, 1996

MedImmune files IND for HPV vaccine candidate

Dec. 16, 1996

SKB reports new vaccine compositions

Dec. 16, 1996

Affymax researches potential malaria vaccines

Dec. 16, 1996

University of Alberta discovers new chemokine-binding protein

Dec. 16, 1996

Biomira strengthens patent rights to Mucin 1 cancer antigen

Dec. 13, 1996

Positive phase IIa results for therapeutic vaccine for genital warts

Dec. 13, 1996

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Dec. 13, 1996

New immunostimulant from Snow Brand

Dec. 13, 1996

NAVA-Chiron Behring vaccine distribution agreement signed

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...